Dan Gustafson
Dr. Dani
el L. Gustafson earned his bachelor’s degree in Biology from Santa Clara University and his PhD in Cell and Molecular Pharmacology and Physiology from the University of Nevada, Reno. He completed his postdoctoral training in Radiation Biology and Pharmacology at Colorado State University & the University of Colorado Health Sciences Center. Dr. Gustafson spent eight years on the faculty at the University of Colorado Health Sciences Center where he founded the Pharmacology Shared Resource for the CU Cancer Center. He moved to the Flint Animal Cancer Center at Colorado State University in 2007 and currently serves as the Director of Basic Research for the FACC, co-Director of the Drug Discovery & Development Shared Resource and co-Leader of Developmental Therapeutics for the CU Cancer Center and is the Shipley University Chair in Comparative Oncology. The focus of his research program is cancer therapeutics with a focus on pharmacokinetic and pharmacodynamic determinants of anti-cancer drug therapy and comparative aspects of these in pre-clinical, veterinary and human clinical oncology. He has been an author on over 190 original scientific articles in journals and over 120 abstracts presented at national and international conferences in the fields of cancer research and pharmacology.